These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9240138)

  • 21. Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
    Suzuki Y; Mori T; Momose H; Matsuki R; Kogure M; Abe N; Isayama H; Tazuma S; Tanaka A; Takikawa H; Sakamoto Y
    J Gastroenterol; 2022 May; 57(5):387-395. PubMed ID: 35357571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma.
    Chen MF; Jan YY; Hwang TL; Jeng LB; Yeh TS
    Dig Dis Sci; 2000 Feb; 45(2):312-6. PubMed ID: 10711444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic cholangiocarcinoma associated with intrahepatic duct stones.
    Hur H; Park IY; Sung GY; Lee DS; Kim W; Won JM
    Asian J Surg; 2009 Jan; 32(1):7-12. PubMed ID: 19321396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma associated with hepatolithiasis.
    Sato M; Watanabe Y; Ueda S; Ohno J; Kashu Y; Nezu K; Kawachi K
    Hepatogastroenterology; 1998; 45(19):137-44. PubMed ID: 9496503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous Biloma Resulting from Intrahepatic Bile Duct Perforation Coexisting with Intrahepatic Cholelithiasis and Cholangiocarcinoma: A Case Report and Literature Review.
    Suzuki K; Hashimoto T; Osugi S; Toyota N; Omagari K; Tamura A
    Am J Case Rep; 2020 Oct; 21():e926270. PubMed ID: 33064672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY; Shiesh SC; Tsao HC; Lin XZ
    Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma.
    Zhu Y; Zhu Y; Cai F; Zhao J; Liu F
    Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modern imaging in the evaluation of hepatolithiasis.
    Chan FL; Chan JK; Leong LL
    Hepatogastroenterology; 1997; 44(14):358-69. PubMed ID: 9164502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.
    Lee KT; Sheen PC
    J Surg Oncol; 1995 Jun; 59(2):131-5. PubMed ID: 7776654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma.
    Han SL; Zhou HZ; Cheng J; Lan SH; Zhang PC; Chen ZJ; Zeng QQ
    Asian J Surg; 2009 Jan; 32(1):1-6. PubMed ID: 19321395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis.
    Huang MH; Chen CH; Yang JC; Yang CC; Yeh YH; Chou DA; Mo LR; Yueh SK; Nien CK
    Am J Gastroenterol; 2003 Dec; 98(12):2655-62. PubMed ID: 14687812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic cholangiocarcinoma associated with hepatolithiasis.
    Yoshimoto H; Ikeda S; Tanaka M; Matsumoto S
    Gastrointest Endosc; 1985 Aug; 31(4):260-3. PubMed ID: 2993092
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral cholangiocarcinoma and intrahepatic calculi.
    Okuda K
    J Gastroenterol Hepatol; 1999 Dec; 14(12):1141-3. PubMed ID: 10634148
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.
    Meng ZW; Han SH; Zhu JH; Zhou LY; Chen YL
    World J Surg; 2017 Mar; 41(3):835-843. PubMed ID: 27766397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
    Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness and limitation of magnetic resonance cholangiopancreatography in patients with hepatolithiasis].
    Park DH; Kim MH; Lee SS; Kim SY; Kim JH; Kim HJ; Bae JS; Seo DW; Lee SK; Kim AY; Kim TK; Min YI
    Korean J Gastroenterol; 2003 Nov; 42(5):423-30. PubMed ID: 14646580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperatively undiagnosable intrahepatic bile duct dilatation contains early-stage intrahepatic cholangiocarcinoma.
    Kinjo N; Shimada M; Maeda T; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2005; 52(65):1368-71. PubMed ID: 16201076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.
    Suzuki Y; Mori T; Yokoyama M; Nakazato T; Abe N; Nakanuma Y; Tsubouchi H; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):617-22. PubMed ID: 24824191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cholesterol hepatolithiasis associated with cholangiocellular carcinoma: a case report and literature review.
    Kawakami H; Kuwatani M; Onodera M; Hirano S; Kondo S; Nakanishi Y; Itoh T; Asaka M
    Intern Med; 2007; 46(15):1191-6. PubMed ID: 17675768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study.
    Jo JH; Chung MJ; Park JY; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB
    Surg Endosc; 2013 Nov; 27(11):4210-6. PubMed ID: 23760942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.